Quantcast

South Brazoria News

Wednesday, November 27, 2024

Carter BloodCare in Dallas, Texas receives FDA inspection

Re 5

Carter BloodCare in Dallas, Texas was inspected by the Food and Drug Administration (FDA) on July 25 for blood and blood products and received one citation, according to data posted on the FDA’s official website.

The FDA website shows that the company was cited for the following problem: 'Failure to maintain donor records.'

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS